The New England journal of medicine, 2017-09, Vol.377 (13), p.1217-1227
2017
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
- Ist Teil von
- The New England journal of medicine, 2017-09, Vol.377 (13), p.1217-1227
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2017
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- In this trial involving patients with atherosclerotic disease who were receiving effective statin therapy, those who were assigned to receive anacetrapib, a CETP inhibitor, had a lower risk of major coronary events than did those in the placebo group.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793, 1533-4406eISSN: 1533-4406DOI: 10.1056/NEJMoa1706444Titel-ID: cdi_swepub_primary_oai_prod_swepub_kib_ki_se_136718402
- Format
- –
- Schlagworte
- Aged, Anticholesteremic Agents - adverse effects, Anticholesteremic Agents - therapeutic use, Arteriosclerosis, Atherosclerosis, Atherosclerosis - complications, Atherosclerosis - drug therapy, Atorvastatin, Cancer, Cardiovascular diseases, Cholesterol, Cholesterol - blood, Cholesterol Ester Transfer Proteins - antagonists & inhibitors, Cholesteryl ester transfer protein, Clinical outcomes, Clinical trials, Coronary Disease - epidemiology, Coronary Disease - mortality, Coronary Disease - prevention & control, Double-Blind Method, Drug therapy, Drug Therapy, Combination, Female, Health risk assessment, Heart attacks, High density lipoprotein, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use, Incidence, Inhibitor drugs, Kaplan-Meier Estimate, Lipids, Low density lipoprotein, Male, Medication Adherence, Medicin och hälsovetenskap, Middle Aged, Myocardial infarction, Oxazolidinones - adverse effects, Oxazolidinones - therapeutic use, Side effects